Evidence map›Paper›PMID 41826882›Full record

ArticleBMC cancer2026

An explainable radiomics model based on multiparametric magnetic resonance for differentiating benign and malignant orbital tumors.

Guozheng Zhang, Xingjian Xu, Rujian Hong, Xiaowei Han, Weitao Huang

Abstract read
In one paragraph

Article in BMC cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Guozheng Zhang *Department of Radiology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, No.100 Minjiang Road, Quzhou, 234000, China.
Xingjian Xu *Zhejiang Chinese Medical University, No.548 Binwen Road, Hangzhou, 310000, China.
Rujian HongDepartment of Radiology, Eye & ENT Hospital, Fudan University, No. 83 Fenyang Road, Shanghai, 200030, China.
Xiaowei HanDepartment of Radiology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, No.100 Minjiang Road, Quzhou, 234000, China.
Weitao HuangDepartment of Radiology, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, No.100 Minjiang Road, Quzhou, 234000, China. 296288883@qq.com.

Funding

Quzhou Municipal Science and Technology Bureau 2022k65
6 · The paper itself

Abstract

objectiveTo develop and internally test a multiparametric radiomics combined model for differentiating benign and malignant orbital tumors. PATIENTS AND

methodsThis retrospective study analyzed 147 patients from two centers (December 2014 to March 2024) with pathologically confirmed orbital tumors and preoperative contrast-enhanced magnetic resonance imaging(MRI). After image preprocessing, 3668 radiomics features were extracted from T2-weighted imaging (T2WI) and contrast-enhanced T1-weighted imaging (CE T1WI) sequences. Feature reduction and selection were performed using the t-test/U-test, Pearson correlation coefficient, minimum redundancy maximum relevance (mRMR), and least absolute shrinkage and selection operator (LASSO) regression. Three machine learning algorithms, logistic regression (LR), naive Bayes classifier (NaiveBayes), and Multilayer perceptron (MLP) were used to construct radiomics models. A combined radiomics model (CRM), defined as an MLP-based model incorporating selected features from both T2WI and CE T1WI sequences, was subsequently built and integrated with clinical factors to create a radiomics nomogram. Model performance was evaluated using the area under the curve (AUC), accuracy, sensitivity, and specificity. Decision curve analysis (DCA) assessed clinical utility, and SHapley Additive exPlanations (SHAP) provided model interpretability.

resultsSix key radiomics features were selected to establish the CRM. The MLP-based model achieved the highest AUC among the individual machine learning models in both training and test cohorts. The CRM demonstrated superior performance compared to models based solely on T2WI or CE T1WI, with AUCs of 0.877 (training cohort) and 0.860 (test cohort). The final nomogram, integrating the CRM and clinical factors, showed favorable discriminatory performance, achieving AUCs of 0.890 and 0.846 in the training and test cohorts, respectively. SHAP analysis identified 'squareroot_firstorder_Skewness_CE T1WI' and 'wavelet_LLH_glcm_Correlation_CE T1WI' as important predictors for malignant orbital tumors.

conclusionThis study presents an effective and explainable multiparametric MRI radiomics model that accurately differentiates benign from malignant orbital tumors. The developed nomogram demonstrates promising performance within the internal validation framework and may provide supportive information for clinical decision-making pending further external validation.

Indexed as

Magnetic Resonance ImagingMultiparametric Magnetic Resonance ImagingOrbital NeoplasmsRadiomicsAdultAgedDiagnosis, DifferentialFemaleHumansMachine LearningMaleMiddle AgedNomogramsRetrospective StudiesYoung AdultBenignMagnetic resonance imagingMalignantNomogramOrbital tumorsRadiomics

Identifiers

PMID41826882
PMCPMC13101340

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.